Indication

Giardiasis

Giardiasis is an enteric parasitic infection of the small intestine caused by the flagellated protozoan *Giardia duodenalis* (also known as *Giardia lamblia* or *Giardia intestinalis*). Read more about Giardiasis

13 drugs 13 manufacturers

Advertisement

Drugs that treat it

Common Giardiasis therapies.

Showing 10–13 of 13 drugs

NITAZOXANIDE

ANTIPROTOZOAL AGENTS·GIARDIASIS·+1
ANI PHARMACEUTI

NITAZOXANIDE

ANTIPROTOZOAL AGENTS·GIARDIASIS·+1
RISING PHARM

TINIDAZOLE

AMEBICIDES, SYSTEMIC·ACUTE INTESTINAL AMEBIASIS DUE TO ENTAMOEBA HISTOLYTICA·+4
EDENBRIDGE/DEXC

NITAZOXANIDE

ANTIPROTOZOAL AGENTS·GIARDIASIS·+1
CAMBER PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Giardiasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Giardiasis.

Giardiasis is an enteric parasitic infection of the small intestine caused by the flagellated protozoan *Giardia duodenalis* (also known as *Giardia lamblia* or *Giardia intestinalis*).

It affects individuals of all ages via the fecal-oral route, with elevated risk among young children, international travelers, and individuals consuming untreated water.

Pathophysiologically, ingested cysts hatch into trophozoites that attach to the duodenal and jejunal brush border, causing enterocyte damage, villous blunting, and malabsorption.

Clinically, infection ranges from asymptomatic colonization to acute or chronic diarrheal illness characterized by watery, foul-smelling, or greasy stools, abdominal cramping, bloating, nausea, and weight loss.

Personalize your experience

Follow Giardiasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it